🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Cardinal Health, Inc. CAH SPX

Healthcare · Medical Distribution · United States
https://www.cardinalhealth.com
Company Profile ↓
$230.11
+43.80% 1Y
Mkt Cap$53.89B
P/E35.08
P/B-18.58
Div. Yield0.91%
52W High$239.71
52W Low$144.54
Book Value$-12.05
EPS (TTM)$6.56

Company Overview

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 16.0%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Jun 2025 Revenue of $222.58B (-1.9% YoY); net profit $1.56B.
  • Trailing 12 Months Year-on-year growth — revenue +11.0%, earnings -19.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 5.4%, profit CAGR 1.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:5.40%
1 Year:11.00%

Compounded Profit Growth

5 Years:1.92%
1 Year:-19.50%

Stock Price Performance

1 Year:+43.80%
6 Months:+14.95%
3 Months:+7.67%
1 Month:+4.27%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 90% of range
$144.54 $239.71
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)54.75 · Neutral
Price Performance
1M+4.27%
3M+7.67%
6M+14.95%
1Y+43.80%
Valuation vs Sector

P/E of 35.08 is above the sector median of 25.41 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
35.08
Industry PE
25.41
Forward P/E
19.18
PEG Ratio
1.39
Book Value
$-12.05
Price to Book
-18.58
P/S
0.21
EV/EBITDA
14.41
Dividend Yield
0.91%

Growth (CAGR)

Revenue 5Y
5.40%
Profit 5Y
1.92%
Revenue (YoY)
11.00%
Earnings (YoY)
-19.50%

Profitability & Returns

ROCE
15.99%
ROE
-56.13%
ROA
3.60%
Profit Margin
0.62%
Op Margin
1.41%
Gross Margin
3.76%
EPS (Latest Qtr)
$1.88
EPS (TTM)
$6.56

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
0.42
Current Ratio
0.91
Debt
$8.92B
Total Assets
$56.69B
Current Assets
$38.06B
Working Capital
$-3.92B

Ownership

Promoter Holding
0.26%
Chg in Prom Hold
-
FII / Inst Holding
90.07%
Chg in FII Hold
0.04%

Financial Snapshot

Enterprise Value
$53.89B
Total Revenue (TTM)
$250.74B
EBITDA
$3.99B
Free Cash Flow
$4.85B
Operating Cash Flow
$5.00B
Shares Outstanding
234.21M
Gross Margin
3.76%
Payout Ratio
31.19%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 CAH Cardinal Health, Inc. SPX 230.11 35.08 $53.89B 0.91% 15.99% -56.13% 5.40% 1.92%
2 LLY Eli Lilly and Company SPX 1,152.54 41.02 $1.03T 0.61% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 253.85 29.45 $611.07B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.78 119.40 $432.48B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 425.19 32.02 $386.13B 2.27% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 120.78 34.02 $298.31B 2.86% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 164.50 24.81 $255.12B 1.77% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 534.07 29.33 $198.47B 0.40% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 355.25 24.69 $191.73B 2.84% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024Sep 2024Dec 2024Mar 2025Sep 2025Dec 2025
Revenue 25.54B25.38B27.55B28.05B31.45B30.66B31.38B32.04B33.15B31.82B32.97B32.64B35.19B33.63B35.35B35.21B37.74B35.23B37.35B37.34B39.73B39.16B36.69B39.06B41.54B39.27B43.97B45.46B44.84B49.59B51.47B50.50B54.65B57.44B54.87B52.28B55.26B54.88B64.01B65.63B
Gross Profit 1.45B1.46B1.46B1.58B1.61B1.69B1.67B1.59B1.60B1.73B1.62B1.67B1.86B1.91B1.74B1.67B1.73B1.76B1.67B1.68B1.71B1.89B1.59B1.72B1.78B1.81B1.64B1.62B1.68B1.60B1.68B1.81B1.74B1.85B1.94B1.90B1.94B2.12B2.32B2.40B
Operating Income 546.00M591.00M-620.00M563.00M656.00M-535.00M542.00M605.00M-262.00M399.00M546.00M-816.00M504.00M432.00M--5.26B334.00M562.00M--624.00M461.00M473.00M415.00M-950.00M-97.00M123.00M-86.00M604.00M-32.00M505.00M369.00M568.00M549.00M730.00M668.00M707.00M
Net Income 289.00M365.00M295.00M383.00M326.00M386.00M333.00M309.00M324.00M381.00M274.00M115.00M1.05B255.00M-1.17B593.00M280.00M296.00M194.00M-4.92B220.00M350.00M656.00M-253.00M629.00M119.00M271.00M49.00M-1.39B98.00M-77.00M365.00M-12.00M368.00M261.00M416.00M400.00M506.00M450.00M467.00M
Diluted EPS 0.861.09-1.150.981.17---------1.94----16.65----0.86--0.94--0.36-0.301.41-0.051.501.071.70--1.88-

Profit & Loss (Annual)

Figures in USD.

Metric Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Revenue 95.99B98.50B102.64B107.55B101.09B91.08B102.53B121.55B129.98B136.81B145.53B152.92B162.47B181.33B204.98B226.83B222.58B
Gross Profit 3.75B3.78B4.16B4.54B4.92B5.16B5.71B6.54B6.54B7.18B6.83B6.87B6.78B6.48B6.87B7.41B8.17B
Operating Income 1.29B1.31B1.51B1.79B996.00M1.89B2.16B2.46B2.12B126.00M2.06B-4.10B472.00M-607.00M752.00M1.24B2.27B
Net Income 1.15B642.00M959.00M1.07B334.00M1.17B1.22B1.43B1.29B256.00M1.36B-3.70B611.00M-938.00M330.00M852.00M1.56B
Diluted EPS 3.181.772.723.060.973.383.624.324.030.814.53-12.612.08-3.371.263.456.45

Balance Sheet (Annual)

Figures in USD.

Metric Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Assets --19.99B22.85B24.26B25.82B26.03B30.14B34.12B40.11B39.95B40.96B40.77B44.45B43.88B43.35B45.12B53.12B
Total Equity 7.75B8.72B5.28B5.85B6.24B5.97B6.40B6.26B6.55B6.81B6.06B6.33B1.79B1.79B-709.00M-2.96B-3.21B-2.78B
Cash & Equivalents 808.80M1.22B2.75B1.93B2.27B1.90B2.87B4.62B2.36B6.88B1.76B2.53B2.77B3.41B4.72B4.08B5.13B3.87B
Long Term Debt --2.13B2.50B--------------
Current Liabilities --11.54B13.37B14.17B14.59B15.12B17.24B19.70B21.22B22.89B24.11B23.61B27.62B30.55B33.74B35.64B38.90B

Cash Flows (Annual)

Figures in USD.

Metric Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Operating Cash Flow 1.42B2.13B1.40B1.18B1.73B2.52B2.54B2.97B1.18B2.77B2.72B1.96B2.43B3.17B2.84B3.76B2.40B
Investing Cash Flow -542.90M127.00M-2.03B-377.00M-2.38B-850.00M-849.00M-4.08B-405.00M-5.61B338.00M493.00M-378.00M567.00M-454.00M-1.85B-5.59B
Financing Cash Flow -468.20M-727.00M-193.00M-454.00M275.00M-710.00M60.00M-1.14B3.75B-2.28B-2.29B-2.20B-1.32B-2.46B-3.05B-847.00M1.94B
Capital Expenditure -421.20M-260.00M-291.00M-260.00M-195.00M-249.00M-300.00M-465.00M-387.00M-384.00M-328.00M-375.00M-400.00M-387.00M-481.00M-511.00M-547.00M
Free Cash Flow 1.00B1.87B1.10B916.00M1.53B2.27B2.24B2.51B797.00M2.38B2.39B1.58B2.03B2.79B2.36B3.25B1.85B
Share Buybacks 0230.00M270.00M450.00M450.00M673.00M1.04B651.00M600.00M550.00M600.00M350.00M200.00M1.00B2.00B750.00M765.00M

Ratios (Annual)

Figures in %.

Metric Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Gross Margin % 3.9%3.8%4.1%4.2%4.9%5.7%5.6%5.4%5.0%5.2%4.7%4.5%4.2%3.6%3.4%3.3%3.7%
Operating Margin % 1.3%1.3%1.5%1.7%1.0%2.1%2.1%2.0%1.6%0.1%1.4%-2.7%0.3%-0.3%0.4%0.5%1.0%
Net Margin % 1.2%0.7%0.9%1.0%0.3%1.3%1.2%1.2%1.0%0.2%0.9%-2.4%0.4%-0.5%0.2%0.4%0.7%
ROE % 13.2%12.2%16.4%17.1%5.6%18.2%19.4%21.8%18.9%4.2%21.5%-206.6%34.1%132.3%-11.2%-26.5%-56.1%
ROCE % -15.5%16.0%17.8%8.9%17.3%16.8%17.1%11.2%0.7%12.2%-23.9%2.8%-4.6%7.8%13.1%16.0%

Shareholding Pattern

Insiders
0.26%
Institutions
90.07%
Public Float
90.30%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 12.17% 28.49M $6.69B
2 Vanguard Capital Management LLC 6.53% 15.29M $3.59B
3 Vanguard Portfolio Management LLC 5.86% 13.73M $3.22B
4 State Street Corporation 5.16% 12.07M $2.84B
5 Geode Capital Management, LLC 2.81% 6.58M $1.55B
6 Morgan Stanley 2.12% 4.95M $1.16B
7 Wellington Management Group, LLP 1.83% 4.28M $1.00B
8 FMR, LLC 1.81% 4.24M $996.44M
9 WCM Investment Management, LLC 1.71% 4.01M $940.88M
10 Invesco Ltd. 1.50% 3.51M $824.78M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CAH

Google News ue, 14 Jul 2026

Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQSUJmMkRzcTRCcEdkLWQ1ME0taTNmb1I0aFhCdkg0QnNmdERIeGl6bU5RZ3FERENyOEJqalZBYUVfWkJpYk1pTTF5eUlFVVVGeW1fblRMMTVJWG5NSk1zN0RiV01JdlV5eVNtOGxpNmdza2I2d2ZhZVZQeTc2bTFDM0NmYm5xaldqUXZBNE…

Google News ue, 14 Jul 2026

Former Solaris Health CEO Takes Helm of National Cardiology Platform - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNRTY3Y1JOMFNCNktxOFVTc3gwMGFBX2o2NlhkdzFCc2Q5TFZ6UFdkaUhXaGhVU3d1MTdSMDlEWS16cXdzeXZtcWx1Vjh3Q1IwVUFHWXVmMmptRElIQjFIY2lKdEN1amhoOUI4ZVJ3WVl4QjNLY0lfeXRkdmpLUmtVT1Z4TXdmZ0VQeU5BY3…

Google News Wed, 15 Jul 2026

Is Cardinal Health (CAH) Still Undervalued As Specialty Growth Lifts Expectations? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPcGwzbnFkQ3pyRzJHbFQwbUFHSksybkZKRElBSEFCNWJLMmhXMFNVZ2dKakNUNVMyRVBIcVlGeGcxbXVEam52ZXk3YWV2YktRcXFySC1xWHVtVUF0R1RMSmZEVHNlWTJCYXhQSFBPZHluakZMRTJNVzMxUVlDVi04MjZFN0dLZ1Z5Nk45bH…

Google News ue, 14 Jul 2026

Cardinal Health (CAH) Stock Looks Strong On Returns Yet Above Fair Value - simplywall.st

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNVUQyNGliMU1TREZva1l3NUxaTm5YTDZhRE5qVW9icVVxbDhSMV9COEliWkRIVG5UUGY4d0w5VW1SQ2dmNE9UNEltN3VQSC1xT1FyWGY0b0hQZWc3dkhTNnJ6eG94XzdzcnF4U3lYaVVLM0pmNTY3NEwtZDdtcjRUSVNSclVHUFFqU0lnM3…

Google News hu, 09 Jul 2026

Should You Retain CAH Stock After Removal From Several Russell Indices? - Zacks Investment Research

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOOGFzV3JEcE51NmVQR0FJcEZTLTV1aHBBRXNBTUZyZGxrSm9INWRWaERXNy14M3o0Z3NSYWhJVDNIX0RzT3lvMXlPc000UVQyWllTekEzVzlzVzBQYTFQeWRXVmRGQzd1ekg0VklQNVRZQ2dnX3EtV0Utb3YwN016SXF4SVNvck9VdXpBb3…

Google News ue, 14 Jul 2026

Cardinal Health (CAH) Stock Looks Overvalued Following Fresh Earnings Beat Hopes - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQNW11dDhteklvOHhSaWJoVFE4WkUxNVhnTlpId3NvcGtRTnRyVF9xTi1fZk1kMnpKbTVWWko2OWNNYU96XzhfMUpEaFJfVHNTSEFhc2RGWmZiRm9IOFA5dmtrUHNOcDR2YVJ3TWpKQ0dqZ3V0RUJNOU1TVENEbUtlVDBFSmRKQmdhenpMYV…

CAH — Frequently Asked Questions

What is the current share price of Cardinal Health, Inc. (CAH)?

As of 2026-07-14 21:23 PDT, Cardinal Health, Inc. (CAH) trades at $230.11 on NYSE. Its 52-week range is $144.54 to $239.71.

What is the market capitalisation of CAH?

Cardinal Health, Inc. (CAH) has a market capitalisation of $53.89B on NYSE.

What is the P/E ratio of CAH?

CAH trades at a trailing price-to-earnings (P/E) ratio of 35.08. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is -18.58.

Does CAH pay a dividend?

Cardinal Health, Inc. (CAH) currently offers a dividend yield of 0.91%.

What is the return on equity (ROE) of CAH?

CAH has a return on equity (ROE) of -56.13%. Its return on capital employed (ROCE) is 15.99%.

Is CAH a good stock to buy?

This page provides a data-driven analysis of Cardinal Health, Inc. (CAH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space